Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

SHE:300194 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	846.31	991.84	688.53	981.13	853.39
Trading Asset Securities	30	5.05	15.21	20.86	75.67
Cash & Short-Term Investments	876.32	996.89	703.74	1,002	929.05
Cash Growth	-12.10%	41.66%	-29.77%	7.85%	7.83%
Accounts Receivable	255.39	359.39	433.24	393.02	370.1
Other Receivables	16.61	23.8	18.92	19.66	17.89
Receivables	272.01	383.19	452.16	412.68	387.98
Inventory	850.97	707.8	719.75	631.92	590.17
Prepaid Expenses	-	-	-	-	0.34
Other Current Assets	66.39	38.36	51.42	38.6	41.76
Total Current Assets	2,066	2,126	1,927	2,085	1,949
Property, Plant & Equipment	1,767	1,736	1,696	1,446	1,222
Long-Term Investments	1,216	1,183	1,072	752.43	699.42
Goodwill	261.18	261.18	485.69	508.66	709.72
Other Intangible Assets	441.2	401.71	383.81	382.37	1,015
Long-Term Deferred Tax Assets	60.54	65.81	101.86	49.15	40.16
Long-Term Deferred Charges	104.84	138.52	176.2	170.25	135.89
Other Long-Term Assets	62.14	63.37	35.35	312.58	201.07
Total Assets	5,979	5,976	5,878	5,706	5,973
Accounts Payable	436.39	379.48	385.07	289.77	216.04
Accrued Expenses	45.05	225.43	253.93	232.76	225.46
Short-Term Debt	333.32	349.11	406.34	642.15	477.5
Current Portion of Long-Term Debt	178.42	54.06	2.51	-	-
Current Portion of Leases	-	0.98	0.58	-	19.91
Current Income Taxes Payable	21.58	15.52	6.62	9	12.46
Current Unearned Revenue	53.93	51.25	61.96	57.15	56.21
Other Current Liabilities	158.31	119.22	170.04	57.66	53.95
Total Current Liabilities	1,227	1,195	1,287	1,288	1,062
Long-Term Debt	193.54	487.14	303.7	263.88	124.21
Long-Term Leases	0.49	1.57	1.06	-	-
Long-Term Unearned Revenue	109.91	92.36	98.06	75.03	53.09
Long-Term Deferred Tax Liabilities	49.5	51.09	64.35	35.92	31.64
Other Long-Term Liabilities	0.01	0.01	177.27	177.27	147.25
Total Liabilities	1,580	1,827	1,932	1,841	1,418
Common Stock	1,190	1,190	1,190	1,190	1,190
Additional Paid-In Capital	2,237	2,237	2,227	2,227	2,231
Retained Earnings	952.26	731.91	559.53	354.92	711.32
Comprehensive Income & Other	16.74	-13.98	-31.58	-37.96	-31.74
Total Common Equity	4,396	4,145	3,945	3,734	4,100
Minority Interest	2.25	3.92	1.38	131.75	454.87
Shareholders' Equity	4,398	4,149	3,946	3,866	4,555
Total Liabilities & Equity	5,979	5,976	5,878	5,706	5,973
Total Debt	705.78	892.86	714.2	906.03	621.62
Net Cash (Debt)	170.54	104.03	-10.45	95.96	307.43
Net Cash Growth	63.93%	-	-	-68.79%	-58.79%
Net Cash Per Share	0.15	0.09	-0.01	0.08	0.26
Filing Date Shares Outstanding	1,045	1,190	1,190	1,190	1,190
Total Common Shares Outstanding	1,045	1,190	1,190	1,190	1,190
Working Capital	838.7	931.19	640.01	796.7	887.77
Book Value Per Share	4.21	3.48	3.32	3.14	3.45
Tangible Book Value	3,693	3,482	3,076	2,843	2,376
Tangible Book Value Per Share	3.54	2.93	2.59	2.39	2.00
Buildings	-	1,177	875.88	871.16	724.77
Machinery	-	1,526	1,347	1,225	1,072
Construction In Progress	-	155.84	695.25	441.2	427.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.